|
|
 |
|
Viewing report
|
|
|
|
Vicor Technologies, Inc. (VCRT) - Financial and Strategic SWOT Analysis Review
GlobalData, Sep 2011, Pages: 38
Vicor Technologies, Inc. (VCRT) - Financial and Strategic SWOT Analysis Review
Summary
Vicor Technologies, Inc. (Vicor) is a US-based development stage medical diagnostics company. It mainly focuses on the commercialization of advanced risk stratification technology. Currently, the company is involved in the commercialization of two proprietary diagnostic medical products, employing software utilizing the PD2i Algorithim, namely, the PD2i Analyzer and the PD2i-V. The PD2i Analyzer displays and analyzes electrocardiographic (ECG) information and measures heart rate variability (HRV) in patients at rest and in response to controlled exercise and paced respiration. The PD2i-VS product, developed in collaboration with the US Army, assesses the severity of critically injured combat casualties to determine the need for immediate life saving intervention in those trauma victims who are at high risk of imminent death. Vicor is also involved in the research of new drugs, currently researching the proteins released during hibernation which look to make promising therapies for blood pressure, cardiac ischemia and stroke. The company has presence across the United States. It is headquartered in Boca Raton, Florida, the US.
Vicor Technologies, Inc. Key Recent Developments
Apr 05, 2011 Vicor Technologies Submits Response To FDA Regarding 510(k) For Cardiac Marketing Claim For PD2i Nonlinear Algorithm
Feb 23, 2011 Vicor Technologies Signs Distribution Agreement For PD2i Products In Israel And Palestine
Feb 02, 2011 Vicor Technologies Names Steve Watts As Director, Sports Medicine
Jan 06, 2011 Vicor Appoints Thomas Bohannon As CFO
Nov 16, 2010 Vicor Technologies Announces New Directors
This comprehensive SWOT profile of Vicor Technologies, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Acura Pharmaceuticals, Inc. (ACUR) - Financial and Strategic SWOT Analysis Review
Anapharm Inc. - Strategic SWOT Analysis Review
Hikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review
Amylin Pharmaceuticals, Inc. (AMLN) - Financial and Strategic SWOT Analysis Review
Valeant Pharmaceuticals International, Inc. (VRX) - Financial and Strategic SWOT Analysis Review
Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review
Transdel Pharmaceuticals, Inc. (TDLPD) - Financial and Strategic SWOT Analysis Review
Alliance Healthcare Services, Inc. (AIQ) - Financial and Strategic SWOT Analysis Review
Access Pharmaceuticals, Inc. (ACCP) - Financial and Strategic SWOT Analysis Review
Bioneer Corporation (064550) - Financial and Strategic SWOT Analysis Review
|
|
|
|
